US Patent 11891448 Glycated CD59 peptides, their preparation, and uses thereof
Patent 11891448 was granted and assigned to President and Fellows of Harvard College on February, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 9 Feb, 2024
Golden AI
Edits made to:
Infobox (+23 properties)
Article (+564 characters)
US Patent 11891448 Glycated CD59 peptides, their preparation, and uses thereof
Article
Patent abstract
The present invention provides glycated Amadori products of the CD59 peptide and fragments thereof to be used as tools and among methods for the diagnosis and prognosis of pre-diabetes and diabetes. Certain aspects of the invention include glycated Amadori products of CD59 and fragments thereof to be used for the generation of antibodies and antibody fragments. Still other aspects of the invention include methodologies for the preparation of glycated Amadori products of CD59, fragments thereof, the inventive antibodies, and antibody fragments.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Jose A. Halperin0
Michael Chorev0
Date of Patent
February 6, 2024
0Patent Application Number
175165080
Date Filed
November 1, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11891448 Glycated CD59 peptides, their preparation, and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
